ICU Medical (ICUI) Set to Announce Quarterly Earnings on Tuesday

ICU Medical (NASDAQ:ICUI) will be announcing its earnings results after the market closes on Tuesday, February 27th. Analysts expect the company to announce earnings of $1.04 per share for the quarter.

ICU Medical (NASDAQ ICUI) opened at $226.20 on Tuesday. The firm has a market capitalization of $4,550.00, a price-to-earnings ratio of 147.84, a P/E/G ratio of 2.39 and a beta of 0.42. ICU Medical has a 52-week low of $142.01 and a 52-week high of $240.20. The company has a current ratio of 4.65, a quick ratio of 3.01 and a debt-to-equity ratio of 0.07.

In related news, Director Robert S. Swinney sold 724 shares of the company’s stock in a transaction on Friday, January 19th. The stock was sold at an average price of $235.00, for a total transaction of $170,140.00. Following the transaction, the director now directly owns 14,830 shares of the company’s stock, valued at $3,485,050. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Scott E. Lamb sold 23,624 shares of the company’s stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $220.00, for a total value of $5,197,280.00. Following the transaction, the chief financial officer now directly owns 29,723 shares in the company, valued at $6,539,060. The disclosure for this sale can be found here. Insiders have sold 25,348 shares of company stock worth $5,582,520 over the last three months. 13.60% of the stock is owned by insiders.

Separately, Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $232.00 price target on the stock in a research report on Thursday, November 16th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $266.00.

ILLEGAL ACTIVITY NOTICE: This report was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Earnings History for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit